3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
14
Triple Negative Breast Neoplasms
12
Carcinoma, Non-Small-Cell Lung
10
Esophageal Squamous Cell Carcinoma
8
Breast Neoplasms
8
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Small Cell Lung Carcinoma
6
Neoplasms
6
Advanced Solid Tumor
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Head and Neck Neoplasms
5
Urinary Bladder Neoplasms
4
Recurrence
4
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Solid Tumor
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Carcinoma, Transitional Cell
3
Turcot syndrome
2
Sarcoma
2
Oropharyngeal Neoplasms
2
Nasopharyngeal Neoplasms
2
NSCLC
2
Muscle Invasive Bladder Cancer (MIBC)
2
Carcinoma, Squamous Cell
2
Biliary Tract Neoplasms
2
Advanced Solid Tumors
2
Interventions
pembrolizumab
119
Cisplatin
33
lenvatinib
29
Carboplatin
28
Paclitaxel
27
Docetaxel
14
Pemetrexed
13
Fluorouracil
12
Capecitabine
11
Saline Solution
10
Oxaliplatin
10
Gemcitabine
10
Albumin-Bound Paclitaxel
7
olaparib
6
Leucovorin
6
Bevacizumab
6
epacadostat
5
belzutifan
5
Etoposide
5
Cetuximab
5
130-nm albumin-bound paclitaxel
5
trifluridine tipiracil drug combination
3
regorafenib
3
patritumab deruxtecan
3
enzalutamide
3
enfortumab vedotin
3
durvalumab
3
Surgical Procedures, Operative
3
Radiotherapy
3
Levoleucovorin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
toripalimab
×
1 year
×
Clear all
No trials found.